[1] |
Martinez Rodriguez RH, Buisan Rueda O, Ibarz L. Bladder cancer: present and future[J]. Med Clin(Barc), 2017, 149(10): 449-455.
|
[2] |
Chen C, Deng Y, Hu X, et al. Mir-128-3p regulates 3t3-l1 adipogenesis and lipolysis by targeting pparg and sertad2[J]. J Physiol Biochem, 2018, 74(3): 381-393.
|
[3] |
Chen GH, Xu CS, Zhang J, et al. Inhibition of mir-128-3p by tongxinluo protects human cardiomyocytes from ischemia/reperfusion injury via upregulation of p70s6k1/p-p70s6k1[J]. Front Pharmacol, 2017, 8(2): 775.
|
[4] |
Mao G, Ren P, Wang G, et al. Microrna-128-3p protects mouse against cerebral ischemia through reducing p38alpha mitogen-activated protein kinase activity [J]. J Mol Neurosci, 2017, 61(2): 152-158.
|
[5] |
Chen J, Li W, Li Y, et al. Microrna-128-3p impaired water maze learning by suppressing doublecortin expression in both wild type and abeta-42 infused mice[J]. Neurosci Lett, 2016, 626(1): 79-85.
|
[6] |
Xia Z, Meng F, Liu Y, et al. Decreased mir-128-3p alleviates the progression of rheumatoid arthritis by up-regulating the expression of tnfaip3[J]. Biosci Rep, 2018,38(4):31.
|
[7] |
Zhou J, He Z, Guo L, et al. Mir-128-3p directly targets vegfc/vegfr3 to modulate the proliferation of lymphatic endothelial cells through Ca2+ signaling[J]. Int J Biochem Cell Biol, 2018,102(9):51-58.
|
[8] |
Huang YCH, Huang XP, Zhu JY, et al. miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients[J]. Oncol Rep, 2015, 33(6):2889-2898.
|
[9] |
Zhang R , Liu C , Niu Y , et al. MicroRNA-128-3p regulates mitomycin C-induced DNA damage response in lung cancer cells through repressing, SPTAN1[J]. Oncotarget, 2017, 8(35): 58098-58107.
|
[10] |
Zhao L, Li R, Xu S, et al. Tumor suppressor mir-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting zeb1 in esophageal squamous-cell cancer[J]. Acta Biochim Biophys Sin(Shanghai), 2018, 50(2): 171-180.
|
[11] |
Wang X, Wu G, Cao G, et al. Microrna335 inhibits bladder cancer cell growth and migration by targeting mitogenactivated protein kinase 1[J]. Mol Med Rep, 2016, 14(2): 1765-1770.
|
[12] |
Xu M, Li J, Wang X, et al. Mir-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting snail and mapk1/slug/vimentin feedback loop[J]. Cell Death Dis, 2018, 9(2): 209.
|
[13] |
Yu WW, Jiang H, Zhang CT, et al. The snail/mir-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer[J]. Oncotarget, 2017, 8(24): 39280-39295.
|
[14] |
Lin Y, Wu Z. Microrna-128 inhibits proliferation and invasion of glioma cells by targeting COX-2[J]. Gene, 2018, 658(5): 63-69.
|
[15] |
Zhou XU, Qi L, Tong S, et al. Mir-128 downregulation promotes growth and metastasis of bladder cancer cells and involves vegf-c upregulation [J]. Oncol Lett, 2015, 10(5): 3183-3190.
|
[16] |
Lin L, Chen X, Peng X, et al. Microrna-128 promotes cell-cell adhesion in u87 glioma cells via regulation of EphB2[J]. Oncol Rep, 2013, 30(3): 1239-1248.
|
[17] |
Song H, Tao Y, Ni N, et al. Mir-128 targets the cc chemokine ligand 18 gene(ccl18) in cutaneous malignant melanoma progression[J]. J Dermatol Sci, 2018, 91(3): 317-324.
|
[18] |
Labernadie A, Kato T, Brugués A, et al. A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion[J]. Nat Cell Biol, 2017, 19(3): 224-237.
|
[19] |
Wang W, Yi M, Zhang R, et al. Vimentin is a crucial target for anti-metastasis therapy of nasopharyngeal carcinoma[J]. Mol Cell Biochem, 2018, 438(1-2): 47-57.
|
[20] |
Jia S, Lu J, Qu T, et al. MAGI1 inhibits migration and invasion via blocking MAPK/ERK signaling pathway in gastric cancer[J]. Chin J Cancer Res, 2017, 29(1): 25-35.
|
[21] |
Delaney J, Chiarello R, Villar D, et al. Regulation of c-fos, c-jun and c-mycgene expression by angiotensin II in primary cultured rat astrocytes: role of ERK1/2 MAP kinases[J]. Neurochem Res, 2008, 33(3): 545-550.
|